Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Case ReportImages in Rheumatology

A Great Masquerader: Chronic Active Epstein-Barr Virus for the Rheumatologist

AMIELEENA CHHABRA, RAIDAN ALYAZIDI and ANDREA HUMAN
The Journal of Rheumatology August 2019, 46 (8) 960-961; DOI: https://doi.org/10.3899/jrheum.180618
AMIELEENA CHHABRA
Division of Rheumatology, Department of Pediatrics, BC Children Hospital, University of British Columbia;
MD
Roles: Subspecialty Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: amieleena{at}yahoo.com
RAIDAN ALYAZIDI
BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada, and Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia;
MBBS, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREA HUMAN
Division of Rheumatology, BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
MD, FRCPC
Roles: Clinical Assistant Professor of Pediatrics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Chronic active Epstein-Barr virus (CAEBV) infection is an EBV-associated lymphoproliferative disease defined by (1) illness lasting > 6 months; (2) infiltration of tissues with lymphocytes; (3) elevated EBV DNA, RNA, or proteins in affected tissues; and (4) the absence of any other immunosuppressive condition1,2. It has 2 forms: EBV-associated T/natural killer (NK) cell proliferation, and EBV-associated B cell proliferation3. In addition to chronic mononucleosis symptoms, the clinical spectrum includes mucocutaneous disease, uveitis, encephalitis, vasculitis, myocarditis, and hemophagocytosis, thus potentially mimicking rheumatic disease1,2,3,4,5.

A 9-year-old girl presented with recurrent angioedema and mouth ulcers following 6 months of perioral rash, fevers, night sweats, headaches, and weight loss. Examination revealed periorbital edema, tongue and lip swelling, and diffuse oral mucosal ulceration (Figure 1), tachycardia, hepatomegaly, and bilateral anterior uveitis. Echocardiography revealed coronary aneurysms, but further testing was not suggestive of vasculitis. Infectious investigation revealed high EBV viral load > 58,000 copies/ml peripheral blood, indicating active EBV infection despite serology consistent with past exposure. A mucosal biopsy reviewed by the National Institutes of Health confirmed CAEBV by demonstrating increased EBV-positive cells that were CD3+ and CD20− on double-staining, consistent with the T/NK cell subtype.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Mucosal irritation and edema.

Given the progressive, life-threatening natural history of CAEBV, the patient underwent a hematopoietic stem cell transplant 7 months following diagnosis. Unfortunately, she died shortly thereafter of posttransplant complications.

CAEBV has multiple manifestations that overlap with autoimmune and inflammatory conditions, including vasculitis4,5. Rheumatologists should consider this rare diagnosis when evaluating patients with complex clinical presentations. CAEBV causing angioedema has not been previously reported.

Acknowledgment

The authors thank the US National Institutes of Health for their help and support in interpretation of pathology and establishing a diagnosis.

Footnotes

  • Ethics approval was not required from the institutions’ ethics board for this case report. Written and informed consent was obtained from the patient/parent.

REFERENCES

  1. 1.↵
    1. Rickinson AB
    . Chronic, symptomatic Epstein-Barr virus infections. Immunol Today 1986;7:13–4.
    OpenUrlCrossRef
  2. 2.↵
    1. Cohen JI,
    2. Jaffe ES,
    3. Dale JK,
    4. Pittaluga S,
    5. Heslop HE,
    6. Rooney CM,
    7. et al.
    Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011;117:5835–49.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Cohen JI,
    2. Kimura H,
    3. Nakamura S,
    4. Ko YH,
    5. Jaffe ES
    . Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol 2009;20:1472–82.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Kimura H,
    2. Cohen JI
    . Chronic active Epstein-Barr virus disease. Front Immunol 2017;8:1867.
    OpenUrlCrossRef
  5. 5.↵
    1. Muneuchi J,
    2. Ohga S,
    3. Ishimura M,
    4. Ikeda K,
    5. Yamaguchi K,
    6. Nomura A,
    7. et al.
    Cardiovascular complications associated with chronic active Epstein-Barr virus infection. Pediatr Cardiol 2009;30:274–81.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 8
1 Aug 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Great Masquerader: Chronic Active Epstein-Barr Virus for the Rheumatologist
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Great Masquerader: Chronic Active Epstein-Barr Virus for the Rheumatologist
AMIELEENA CHHABRA, RAIDAN ALYAZIDI, ANDREA HUMAN
The Journal of Rheumatology Aug 2019, 46 (8) 960-961; DOI: 10.3899/jrheum.180618

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
A Great Masquerader: Chronic Active Epstein-Barr Virus for the Rheumatologist
AMIELEENA CHHABRA, RAIDAN ALYAZIDI, ANDREA HUMAN
The Journal of Rheumatology Aug 2019, 46 (8) 960-961; DOI: 10.3899/jrheum.180618
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • An Uncommon Mimic of Spondyloarthritis
  • A Rare and Severe Cutaneous Presentation of Systemic Lupus Erythematosus
  • A Case of Disseminated Nocardiosis in an Elderly Patient Receiving Long-Term Glucocorticoid Therapy for Polymyalgia Rheumatica
Show more Images in Rheumatology

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire